January 15, 2017
Platform manufacturing keeps driving the industrialization of bioprocessing, both upstream and downstream. Upstream operations, risk averse as ever, are using the new platform approaches to do the usual: push raw production. And it must be said that downstream operations are hardly more daring. Yes, they sometimes seek innovation—but always prudently. Read the full article here.
January 5, 2017
Winners CADENCE BIOSMB SYSTEMS Multi-column chromatography system for purification processes up to 2000L. Produced by Pall Life Sciences The Cadence BioSMB process system is a fully scalable, disposable flow path, continuous multi-column chromatography solution – a market first, according to the company. It is designed for easy conversion from an existing process developments scale continuous […]
January 1, 2017
If you did any baking during the holidays, you learned (or relearned) that scaleup involves more than multiplying ingredient quantities, container sizes, and cooking times. As with adjustments to baking recipes, so it is with more complicated scaleup projects—such as those encountered in bioprocessing. Read the full article here.
Overcoming the Challenges of Traditional Chromatography Solutions with Technology Michelle Najera, Ph.D. Downstream bioprocessing steps have long been a challenge to drug manufacturers, particularly the chromatography step for purification of monoclonal antibodies (mAbs). The complexity of traditional chromatography options, as well as the high cost of the Protein A resin required, have driven the search […]
To ensure you are continuous ready, subscribe for further updates: